A solitary cluster of parvalbumin-positive neuronsthe PV1 nucleus -has been observed in the lateral hypothalamus of rodents. In the present study, we mapped the efferent connections of the PV1 nucleus using nonspecific antero-and retrograde tracers in rats, and chemoselective, Cre-dependent viral constructs in parvalbumin-Cre mice. In both species, the PV1 nucleus was found to project mainly to the periaqueductal grey matter (PAG), predominantly ipsilaterally. Indirectly in rats and directly in mice, a discrete, longitudinally oriented cylindrical column of terminal fields (PV1-CTF) was identified ventrolateral to the aqueduct on the edge of the PAG. The PV1-CTF is particularly dense in the rostral portion, which is located in the supraoculomotor nucleus (Su3). It is spatially interrupted over a short stretch at the level of the trochlear nucleus and abuts caudally on a second parvalbumin-positive (PV2) nucleus. The rostral and the caudal portions of the PV1-CTF consist of axonal endings, which stem from neurons scattered throughout the PV1 nucleus. Topographically, the longitudinal orientation of the PV1-CTF accords with that of the likewise longitudinally oriented functional modules of the PAG, but overlaps none of them. Minor terminal fields were identified in a crescentic column of the lateral PAG, as well as in the Edinger-Westphal, the lateral habenular, and the laterodorsal tegmental nuclei. So far, no obvious functions have been attributed to this small, circumscribed column ventrolateral to the aqueduct, the prime target of the PV1 nucleus.
The lateral hypothalamic area (LHA) is a complex region consisting of many different cell types mingling with the longitudinally directed fibers of the medial forebrain bundle (mfb). In early studies, the projections of the LHA could not be distinguished from those of axons traveling in the medial forebrain bundle by using degenerative techniques (Guillery, 1957; Chi and Flynn, 1971) . However, with the advent in the 1970s of more sophisticated, axonal transport-tracing techniques, the anterior, tuberal, and posterior regions of the LHA were found to have different patterns of projection (Saper et al., 1976 (Saper et al., , 1979 Berk and Finkelstein, 1982) . More recently, the projections of much smaller regions of the LHA, such as the juxtadorsomedial, juxtaparaventricular, and suprafornical regions, have been examined by using Phaseolus vulgaris leucoagglutinin (PHA-L) as an anterograde tracer and cholera toxin B (CTB) as a retrograde tracer Swanson, 2010, 2012) . However, these pathways include axons stemming from many chemically and physiologically distinct neuronal populations, which makes it difficult to elucidate their potential functional significance.
The identification of neuropeptides that are specific to the LHA has permitted a much more precise delineation of the connections of the nerve cells that synthesize them. For example, the projections of the orexin-(or hypocretin) secreting neurons and the neighboring melanin-concentrating hormone-secreting neurons can be readily traced, as these peptides are synthesized by cells occurring exclusively in the LHA. Consequently, their projections can be revealed immunohistochemically (Bittencourt et al., 1992; Peyron et al., 1998; Chemelli et al., 1999) . Although these studies have furnished useful information regarding the possible functions of the implicated cell groups, the methodology is of course applicable only to those neuronal populations of the LHA that contain unique peptides. A more common situation is exemplified by the parvalbumin-positive (PV1) nucleus (Celio, 1990; Girard et al., 2011; Meszar et al., 2012) , which is lodged in the LHA, adjacent to the optic tract. Although the group of PV-positive neurons in this location is quite distinct, many other PV-immunoreactive neurons are scattered throughout the brain. Consequently, the projections of the PV1 nucleus cannot be inferred simply by following the ramifications of PV-immunoreactive axons. To characterize the projections of the PV1 nucleus in the present study, nonselective anterograde and retrograde tracing methods were utilized in rats, and chemoselective tracing techniques in PV-Cre mice (Hippenmeyer et al., 2005) . In the latter approach, adeno-associated viral (AAV) vectors expressing red or green fluorescent proteins in a Cre-dependent manner (Yonehara et al., 2011) were injected into the PV1 nucleus of PV-Cre mice. These experiments in rodents permitted us to identify a narrow column located at the edge of the periaqueductal gray (PAG), ventrolateral to the aqueduct, as the prime projection target of the PV1 nucleus.
MATERIALS AND METHODS
The overall study was approved by the Veterinary Commission for Animal Research of the Canton of Fribourg, Switzerland. All animals prepared for this study were housed in state-of-the art animal facilities according to the strict Swiss animal experimentation law. Other animals, drawn from previously published studies Moga et al., 1990; Hurley et al., 1991) , had been housed at the University of Chicago Pritzker School of Medicine animal facility, and protocols had been approved by that institution's animal care and use committee.
Rat tracing experiments
Wistar rats of both sexes, weighing 275-300 g, were used for the current study. A substantial body of the data presented is drawn from the retrospective analysis of archival specimens that had been prepared for previously published studies Moga et al., 1990; Hurley et al., 1991) . The methods used in those experiments were described in detail in those publications, and involved anterograde and retrograde tracing with wheat germ agglutininhorseradish peroxidase (WGA-HRP), revealed by a tetramethylbenzidine method, and anterograde tracing with PHA-L, demonstrated immunohistochemically.
Antero-and retrograde tracing
The animals prepared for the current study were deeply anesthetized with a mixture of Ketalar (ParkeDavis, Ann Arbor, MI; 75 mg/kg of body weight) and xylazine (Streuli, Uznach, Switzerland; 10 mg/kg of body weight) prior to tracer application and perfusion. By using a Kopf (Tujinga, CA) stereotactic apparatus, the brains of six rats were bilaterally injected in the region of the PV1 nucleus of the lateral hypothalamus with 20 nl of biotinylated dextran amine at the following coordinates: anteroposterior Bregma 22.56 mm; dorsoventral 28.6 mm; lateral 12.4 mm and 22.4 mm. After 2 weeks, rats were perfused with 0.9% NaCl, followed by 4% paraformaldehyde (in 0.1 M phosphate buffer, pH 7.3; PFA). The brains were excised and cryoprotected overnight with 18% sucrose. Coronal, 40-lm-thick cryostat sections were prepared from the chemically fixed brains, and incubated for 24-48 hours at 4 C with a monoclonal antibody against parvalbumin (PV 235, Swant, Marly, Switzerland) diluted 1:10,000 in 0.2% Triton X-100 and 10% horse serum. They were washed in the same buffer and then incubated for 2 hours in the dark with goat anti-mouse IgG/Cy2 (1:200; Jackson ImmunoResearch, West Grove, PA) to stain the primary antibody, and with Streptavidin-Cy3 (1:1'000) (Jackson ImmunoResearch) to detect the biotinylated dextran. After washing, sections at the relevant level were mounted and examined with a Zeiss Axiophot fluorescence microscope. In three rats for each site, 30-50 nl of a 4% solution of Fluoro-Gold (Fluorochrome, Denver CO) in saline were injected into one of the following regions: PAG (anteroposterior 26.04 mm; mediolateral 0.8 mm; dorsoventral 25.6 mm) and laterodorsal tegmental nucleus (anteroposterior 28.72 mm; mediolateral 0.8 mm; dorsoventral 27 mm). After sectioning, all slices containing the hypothalamus were incubated with the PV235 antibody and further prepared for indirect fluorescence microscopy as described above.
The archival rat material analysed to trace the connections to the PV1 nucleus is listed in Tables 2 and 3 . These previous experiments revealed the PV1 nucleus to be targeted with fair precision by some injections of WGA-HRP into the lateral hypothalamus . Likewise, retrograde tracing experiments from the midbrain have been reported by Hurley et al. (1991) and Herbert and Saper (1992) .
Mouse tracing experiments
Expression of the enzyme Cre-recombinase in the PVpositive neurons of the PV1 nucleus of PV-Cre mice was demonstrated by breeding 129P2-Pvalb< tm1(cre)Arbr>/J mice (Hippenmeyer et al., 2005 ) with B6;C3-Tg(CAG-DsRed,-EGFP)5Gae/J mice (Jackson Laboratory, Bar Harbor, ME). In the resulting mice, only PV neurons expressing CRE-recombinase synthesize green fluorescent protein, whereas all other neurons remain red. In these mice, all of the PV-positive neurons in the PV1 nucleus were enhanced green fluorescent protein (EGFP)-positive, and all of the EGFP-positive neurons in the PV1 were PV-immunoreactive. Furthermore, PV immunostaining was routinely performed to detect the coexistence of this calcium-binding protein with the viral or the retrograde (e.g., Fluoro-Gold) tracers.
To study the projections of the PV1 cell group in mice (25-35 g body weight), the brains of PV-Cre mice (129P2-Pvalb<tm1(cre)Arbr>/J) (Hippenmeyer et al., 2005) were stereotactically injected with a volume of 20-60 nl on the left side (or bilaterally) at coordinates: anteroposterior Bregma 21.5 mm, mediolateral 1.3 mm, and dorsoventral 4.9-5.1 mm with the following Cre-dependent viral construct (Yonehara et al., 2011): Serotype 7 AAV EF1a-DIO-ChR2-mCherry-WPRE In a few cases (see Table 4 ), the following Cre-dependent constructs were used: Serotype 7 AAV EF1a-DIO-ChR2c-2A-DsRed2-WPRE (e.g., 218/11 dx) AAV2/1.CAG.FLEX.EGFP.WPRE.bGH (e.g. 502/12) AAV2/9.CAG.FLEX.EGFP. WPRE.bGH (e.g. 503/12) In the first construct, the mCherry was a fusion protein with channelrhodopsin, resulting in the red fluorescence being targeted to the outer membranes of the transfected cells. In the second construct, the 2A linker segment was post-translationally deleted, producing DsRed2 protein that was localized to the cytoplasm of transfected neurons. The third and fourth constructs led to the strong expression of EGFP in Cre-positive cells. They were developed by the Allen Institute and are available commercially from the Vector core at the University of Pennsylvania (http://www.med.upenn.edu/gtp/vectorcore/). Retrograde fluorogold tracing experiments were performed similar to those in rats (see above). Four weeks later, the mice were transcardially perfused with 0.9% NaCl followed by 4% PFA. The brains were excised and processed as described above for rats, with the exception that 80-lm-thick (instead of 40-lm) sections were produced. The sections were then incubated with a rabbit PV antiserum (PV25, Swant, Marly) and then processed for double fluorescence with a biotinylated secondary antibody and Streptavidin-Cy2 or Cy3 (or Alexa 488). The sections were mounted and analyzed under either a fluorescence microscope (Zeiss Axiophot equipped with a Spot-camera (2M sampler), a Leica 6000 epifluorescence microscope equipped with a Hamamatsu C4742-95 camera, a Nanozoomer (Hamamatsu), or a confocal microscope (Leica CTR 6500).
Control tracing experiments
Five control experiments were performed to check whether the projection of PV-immunoreactive structures located along the needle track to the PV1 nucleus (e.g., thalamic reticular nucleus, subthalamic nucleus, zona incerta, medial hypothalamus) contributed endings to the terminal fields in the PAG (see Table 4 , experiments 189/11, 415/12, 416/12, 512/12, 513/12) . Injections were performed at different mediolateral (1 mm instead of 1.4 mm) and dorsoventral (4.6 mm instead of 5.1 mm) levels.
Characterization of antibodies (Table 1)
Antibodies against parvalbumin (PV235 and PV28/ 25, all Swant, Marly, Switzerland) recognize only one band of 12 kDa MW in Western blots of brain extract in various species, including rat and mouse. They stain the brain in a pattern consistent with previous results (Celio, 1990) and do not produce staining in the brain of PV knockout mice (Schwaller et al., 1999) .
The CART antibody (H-003-62, lot 00324) used to identify the cortically projecting subdivision of the Edinger-Westphal nucleus was acquired from Phoenix Pharmaceuticals (Burlingame, CA). It was produced against synthetic peptides (amino acids 55-102) with no cross-reaction with similar peptides, and its staining Table 2 . The two small black arrows point to vessels that can also be observed in Figure 5C (white arrows), cut at a similar level in the mouse brain. C: Immunohistochemical revelation of PV to indicate the location and size of the PV1 nucleus at a level corresponding to Figure 1A . Note the paucity of other PV-positive elements in the close surroundings of the PV1 nucleus. D: Anterograde PHA-L tracing of axon terminals stemming from neurons that were injected in the lateral hypothalamic region, which includes the PV1 nucleus (injection 451; see also Table 2 ). These axon terminals are widely distributed throughout the cross-sectional area of the lateral PAG. For abbreviations, see list. Scale bar 5 0.5 mm in A,C; 0.25 mm in B,D.
was inhibited by adsorption with the immunizing peptide (1 lg/ll). The staining pattern was consistent with previous localization results (Kirouac et al., 2006; Reeber and Sillitoe, 2011) .
Photomicrographs
Images were imported in Photoshop (Adobe Systems, San Jose, CA), and contrast, brightness, and sharpness were adapted, if necessary. The image stacks were prepared with ImageJ software, and the figures were mounted with Adobe Illustrator.
RESULTS

Experiments in rats
Tracers that were injected into the ventrolateral part of the hypothalamus always extended beyond the Table 3 ) ventrolateral to the aqueduct is marked with black arrows. The approximate portion ventrolateral to the aqueduct that was exposed to this retrograde tracer is encircled (stippled circle). Note the proximity of the pipette tip to the Su3 region. B: Axon terminals (small colored points) are depicted. Three anterograde tracing experiments are jointly summarized (red, injection R189; yellow, injection R93; and blue, injection R451 (Table 2) . Note the similarities between the three specimens in the distribution patterns of the terminals ventrolateral to the aqueduct (short arrows at levels 26.65, 27.10, and 27.90), in the parabrachial nuclei (PB) and the laterodorsal tegmental nucleus (LDTg). However, most of the terminals in the PB apparently do not come from the PV1 cell group. C: The location of the needle tip in 14 retrograde tracing experiments is indicated by red triangles. Only nine injections located between level 26.65 and 28.60 succeeded in filling retrogradely neurons in the PV1 (see Table  3 , e.g., injection R770, also depicted in Fig. 2A ). These injection sites occupy a virtual "column" (light red) located ventrolateral to the aqueduct and composed of a rostral and a caudal part interrupted approximately at level 27.10 by a short gap. Drawing modified from Swanson (2004) . For abbreviations, see list. Scale bar 5 0.8 mm in A; 1.7 mm in B,C.
borders of the PV1 nucleus (Fig. 1A,B) . In the experiments described here, neurons in the PV1 group did indeed take up the anterograde tracer biotinylated dextran (Fig. 1) or WGA-HRP or PHA-L, but other, unrelated nerve cells likewise transported the injected tracer. Hence, the resulting projections include more than would have been expected if only the PV1 neurons had been targeted. A list of the terminal fields recognized in five such experiments is given in Table 2 , and a schematic drawing of their localization in the mid-and hindbrain is provided in Figure 2B .
The major targets of the lateral hypothalamus known from the literature, received anterogradely labeled axons, including the infralimbic cortex, the septum, the amygdala, the habenula, the lateral PAG (Figs. 1D, 2B ), and the parabrachial nuclei (Fig. 2B) . In three rats, terminal fields of labeled axons were also observed in the ventrolateral part of the PAG (highlighted with different colors-red, blue, and green-in Figure 2B ).
To determine which of these sites might be specific targets of the PV1 nucleus, their inputs were retrogradely traced. Retrogradely labeled neurons in the PV1 nucleus were seen after injections into only the lateral and the ventrolateral PAG (Figs. 2A,C, 4E ) and the laterodorsal tegmental nucleus (Figs. 3, 4B , Table 3 ) of archival and fresh material.
To determine the topography of the PV1 projection to the rat PAG, we examined retrograde labeling after injections in the lateral or ventrolateral PAG, or in the reticular formation just outside the PAG, in 14 cases Paxinos and Watson (1999) . The track left by the micropipette is indicated with thin black arrows. The tip of the micropipette is located within the ventrolateral PAG at the level of the LDTg (fifth arrow). Injection 490 (Table 3) . B-D: Retrograde filling of neurons in the PV1 nucleus of the same animal at three different levels (22.56, 22.80, and 23.30) . In addition to the cells in the PV1 nucleus (arrows), other retrogradely labeled neurons are scattered throughout the lateral hypothalamic area. E,F: Brightfield images of the same PV1 nucleus revealing the presence of some retrogradely labeled neurons of different sizes (arrows in F) and considerable axonal labeling (small spots) suggesting a reciprocal projection. Counterstaining with Nissl stain. For abbreviations, see list. Scale bar 5 0.25 mm in A; 0.3 mm in B-D; 25 lm in E,F.
(the locations of the needle tips are indicated by red triangles in Fig. 2C ). The injection of a retrograde tracer close to the PAG in the rostral midbrain (R266 and R655; level 25.65. Fig. 2B ) did not lead to filling of the nerve cells in the PV1 nucleus (Table 3) . Three injections of a retrograde/anterograde tracer into the pons just ventral to the dorsal tegmental nucleus (R570, R590, and R594; Fig. 2C ) revealed only terminal fields (and a few perikarya) in the region occupied by the PV1 nucleus (Table 3) . Only the nine injections into the ventrolateral quadrant of the midbrain PAG (Fig. 2C ) led to successful retrograde filling of many neurons in the PV1 nucleus (Table 3) . Thus, a longitudinal column of successful retrograde injections in the PV1 nucleus was located in the rat ventrolateral PAG, and spanned a length of approximately 2 mm ( Fig. 2C ; level: 26.65 to 28.60).
As another example, Figure 3A shows the result of a retrograde tracer injection close to the distal ventrolateral PAG and laterodorsal tegmental nucleus. Although other neurons in the lateral hypothalamus were also retrogradely labeled (Fig. 3B-D) , the characteristic PV1 group was nevertheless discernible as an intensely labeled cluster (Fig. 3B-D) . These findings are summarized in Table 3 .
Injections of retrograde tracer in areas such as the lateral septum, the central nucleus of the amygdala, and the parabrachial nuclei, which are known to receive inputs from the lateral hypothalamus, did not lead to labeling of the PV1 nucleus.
Analysis of archival material after retrograde tracing was complemented and confirmed by an evaluation of freshly prepared double-stained specimens: neurons of the lateral hypothalamus that projected to the region of the laterodorsal tegmental region were indeed PV-positive. Figure 4 reveals that when Fluoro-Gold was injected close to the caudal part of the ventrolateral PAG/laterodorsal tegmental nucleus (Fig. 4A,B,E) , it was transported back (Fig. 4C,G) to the small PV-positive neurons (Fig. 4D,H) in the PV1 nucleus of the lateral hypothalamus.
Experiments in mice
In the 129P2-Pvalb<tm1(cre)Arbr>/J 3 B6;C3-Tg(CAG-DsRed,-EGFP)5Gae/J mouse, all PV-immunoreactive neurons of the PV1 nucleus expressed EGFP, thus confirming the presence of Cre-recombinase (Fig.  5A,B) . Notwithstanding the fact that the PV1 nucleus is near other PV-immunoreactive cell groups, the AAVmCherry-labeled neurons were almost entirely within the PV1 nucleus (Fig. 5C,D and E-J). The PV1 nucleus was often clearly visible as a compact cluster of cells emitting a red-fluorescent signal in the outermost part of the ventrolateral hypothalamus (Fig. 5C,D) . Although not all of the PV-positive neurons of the PV1 nucleus were labeled by the viral construct (Fig. 5D ,E-J; see Table 4 for an approximation of the number of infected cells in each experiment), virtually all of the virusinfected neurons were PV-positive. In most cases, small numbers of unrelated PV-positive neurons that lay along the track of the injection needle were labeled (Fig. 6A) . These cells were located in the ventrobasal tip of the thalamic reticular nucleus, the medial edge of the The Cre-dependent adeno-associated virusmCherry construct has been taken up by some of the cells (red) in the PV1 nucleus, which are colabeled with a Cy2-tagged antibody against PV (green). Some of the red (mCherry-labeled) neurons are also green PV-positive cells, so the concurrent fluorescence signals appear yellow. However, a few AAV-infected cells emit only a red signal, owing to the poor penetration of the PV antibody through this (80 lm) thick section. The image in C (experiment 218-11), is taken at the posterior level of the PV1 nucleus, and that in D at its caudal extremity. The two white arrows in C indicate vessels that can also be observed in Figure 1B 
n.e.
n.e. globus pallidus, the subthalamic nucleus, or the lateral mammillary nucleus, as were scattered cells in the medial hypothalamus that send dendrites to the PV1 nucleus. The extent of this spread is summarized in Table 4 . Control injections targeted to these diverse nuclei failed to label terminals in the ventrolateral part Figure 6 . AAV-colabeling of other structures in the mouse diencephalon. A: In addition to the PV1 nucleus, neurons in the medial globus pallidus (MGP, also called the entopeduncular nucleus), the subthalamic nucleus, the reticular nucleus of the thalamus (in the picture only axons are visible for these two structures; cell bodies are at another level) and the Zona incerta also took up the viral construct (see Table 4 for details). of the PAG (injections 189/11, 415/12, 416/1, 512/ 12 and 513/12; see Table 4 ). Axons exited the rostral portion of the PV1 nucleus in the supraoptic commissure (Fig. 6B) , its midregion in the medial forebrain bundle, and its distal portion in the dorsomedial direction (Fig. 5K) . Fluorescent axons in the supraoptic commissure crossed the midline and ended in the contralateral region harboring the PV1 nucleus (Fig. 6B) . Axons of neurons in the PV1 nucleus that ran in the medial forebrain bundle lateral to the mammillary bodies traced a wide path through the ventral tegmental region. At the level of the The third, most prominent, terminal field is encountered ventrolateral to the aqueduct (white arrow in E) at the level of the oculomotor nucleus (3). This terminal field forms a longitudinally orientated cylinder (PV1-CTF), which spans approximately 450 lm in length (see also schematic drawing in Fig. 11 ). Compare this image with that of the retrograde injection in the rat PAG ( Fig. 2A) . Axons enter this fluffy aggregate of terminals from below, and some may come from lateral. The black arrow in E indicates scattered axons in the lateral PAG. Switching of the filter to visualize the PV immunostaining (F) reveals that the axons of the PV1 nucleus terminate in a territory rich in PV-positive endings, harboring only a few PV-positive neurons (bilateral white arrows in F) (injection 66/12, Table 4 ). For abbreviations, see list. Scale bar 5 0.3 mm in A-F. interpeduncular nucleus, the fibers curved dorsally along the midline, converged around the fasciculus retroflexus (Fig. 6D) , and were then concentrated in the region of the Edinger-Westphal nucleus (Fig. 7A) . A second component ran in the descending medial forebrain bundle into the ventromedial tegmentum at the level of the red nucleus, arched dorsolaterally, and then entered the ventrolateral part of the PAG at the level of the oculomotor nuclei ( Fig. 7C-E) .
In the PAG, the axons stemming from the PV1 nucleus terminated mainly ipsilaterally, ventrolateral to the aqueduct on the edge of the PAG in the Su3 region (Paxinos and Franklin, 2001; Paxinos and Watson, 2009; Van Bockstaele et al., 1989) and more sparsely in the lateral region (Figs. 7C,D and E,F, 9A-H) . The dense cloud of terminals ventrolateral to the aqueduct formed a cylindrical column of terminal fields (PV1-CTF) (Figs. 7E, 9A-D,G,H) , whereas the lateral one was crescentic and contained scattered terminals (Figs. 7C, 9) .
The (PV1-CTF) was detectable first at level Bregma 23.88 mm in the atlas of Paxinos and Franklin (2001) and continued until level Bregma 24.30 mm (rostral portion, Figs. 7E,F, 9A-D and 11). After an interruption of approximately 150-200 lm (Figs. 2C, 9F, 11) , the PV1-CTF continued from 24.56 to 4.84 mm (caudal portion, Figs. 8A-D, 9F-H), thus spanning a total length of approximately 1 mm (see details in Table 4 , specimens 64-66/12). The contralateral side also exhibited a similar column of lower terminal density (left in Fig. 8A ). The diameter of the PV1-CTF in the rostral part was of approximately 0.2 mm (Figs. 7E, 9A-D) , and the oval PV1-CTF in the caudal part was 0.4 3 0.2 mm (Figs.  8A,B, 9G,H) .
The terminals in the lateral quadrant first appeared approximately at level Bregma 23.4 mm and continued until level 24.7 mm in the atlas of Paxinos and Franklin (2001) . Both the PV1-CTF ventrolateral of the aqueduct and the lateral quadrant, were discernible as PV-rich areas in sections that had been immunohistochemically stained for PV (Fig. 7D, F) . Qualitatively, the density of terminals in the PV1-CTF seemed to correlate with the number of virus-infected cell bodies in the PV1 nucleus . The cylindrical column of terminal fields (PV1-CTF) ventrolateral to the aqueduct. Images of eight consecutive sections cut through the periaqueductal gray region of brain 64/12. The dense and roundish terminal field ventrolateral to the aqueduct is highlighted by a white arrow and is clearly visible from levels 3.9 to 4.14 (A-D). It vanishes at level 4.24 (E) between section 117 and 119 (Bregma 24.30-4.50), reappears as an oval-shaped terminal field in section 120, and can be followed for some more sections (Figs. F-H (Table 4 ). A precise quantification (e.g., by measuring fluorescence intensities with a confocal microscope) was not attempted. The terminal field ventrolateral to the aqueduct was sometimes traversed by large blood vessels (Fig. 4E,F) .
At caudal levels between 24.56 and 24.84 mm (Paxinos and Franklin, 2001) , the PV1-CTF impinged on an uncharted PV-positive population of neurons (Figs. 8A, B, 11) . At this level the cylindrical column flares out and transcends the borders of the PAG to invade the adjoining reticular formation (Fig. 9F,G) . The PV1-CTF is located medioventral as compared to the ventrolateral column of the PAG described by Bandler et al, 1994 .
Injections of the tracer Fluoro-Gold in this same quadrant at various levels of the PAG resulted in the retrograde filling of PV-positive neurons in the PV1 nucleus of rats (Figs. 2C, 4A-H) and mice (Fig. 10) . When injections were performed at level 27.10 (Fig. 2C , gap at the level of the trochlear nucleus) in the rat, no neurons of the PV1 nucleus could be retrogradely filled with Fluoro-Gold. In the mouse, neurons in the PV1 nucleus were retrogradely labeled only when the rostral or caudal PV1-CTF were hit (Fig. 10) .
The outermost portion of the crescentic quadrant of the lateral PAG receives few terminals from the PV1 nucleus (Fig. 7D) . In sections that were immunostained with antibodies against PV, this region is homogeneously labeled (Fig. 7E) . We assume that the terminals originating from the PV1 nucleus constitute only a small proportion of the inputs to the lateral PAG. Embedded in the superficial, lateral portion of the caudal PAG are the large, PV-positive neurons of the mesencephalic trigeminal nucleus (Figs. 7F, 8B ), which do not appear to be targeted by axons stemming from the PV1 nucleus. However, ultrastructural studies will be needed to confirm this impression.
The axon terminals coming from the PV1 nucleus were located more lateral than the cocaine-and amphetamine-regulated transcript (CART) neurons of the cortically projecting Edinger-Westphal subnucleus (Fig.  6E) .
In some cases, in which large mCherry-labeled, PVpositive neurons were located more medially in the hypothalamus and in the lateral mammillary nucleus, terminals were identified in the dorsal tegmental nucleus (Fig. 6F) . In two cases (189/11 and 218/11) the lateral mammillary nucleus was observed to contain particularly large numbers of transduced neurons, and in those cases the dorsal tegmental nuclei were distinguished by the presence of intensely labeled terminal fields. The terminals probably do indeed derive from the lateral mammillary nucleus, via the mammillotegmental tract (Cruce, 1977; Hayakawa and Zyo, 1990) .
In the tuberal hypothalamus, scattered large PV-positive neurons were seen with horizontal dendrites extending into the PV1 nucleus and were occasionally labeled with the viral construct. In control experiments that targeted only these neurons alone, no projection to the ventrolateral PAG was observed (case 416/12 and 513/12).
In two cases (189/11 and 64/12), which were distinguished by the presence of labeled neurons in the substantia nigra pars reticulata (SNr), inputs to the superior colliculus were particularly striking. The SNr is known to project to the superior colliculus (Cebrian et al., 2005) ; because the inputs to the latter were observed only when cells of the former region were targeted, they probably derive from it. In some specimens, a group of intensely labeled axons were seen that followed a vertical course near the fasciculus retroflexus (Fig. 6D ) and then turned caudally in the ventral PAG. These axons appeared to stem mainly from the larger, most caudally located neurons of the PV1 nucleus, but terminals in the region of the retroflex fascicle could not be identified with certainty.
The projections of the reticular thalamic nucleus are confined to the thalamus, whereas those of the medial segment of the globus pallidus extend to the lateral habenular nucleus (Herkenham and Nauta, 1977) , the subthalamic nucleus, and the substantia nigra (Carter and Fibiger, 1978) . After an injection that left the medial segment of the pallidum unlabeled (237/11), only a few terminals (which possibly stemmed from the PV1 nucleus) were labeled in the lateral habenular nucleus. Hence, only a small proportion of the terminals in the latter structure originate from projections of the PV1 nucleus.
DISCUSSION
This hodological study has revealed that axons stemming from the elongated lateral hypothalamic PV1 nucleus terminate mainly ipsilaterally in a longitudinally oriented cylindrical field ventrolateral to the aqueduct. The injection of antero-and retrograde tracers into the lateral hypothalamus had hitherto disclosed numerous connections with rostral and caudal structures (Wolf and Sutin, 1966; Saper et al., 1979; Matsushita, 1980, 1981; Barone et al., 1981; Oomura, 1981, 1982; Berk and Finkelstein, 1982; Veening et al., 1987; Villalobos and Ferssiwi, 1987; Moga et al., 1990; Hurley et al., 1991) . However, spatially more targeted injections have revealed that relatively few were related to the PV1 nucleus. Indeed, our findings indicate that the hypothalamic PV1 nucleus projects almost exclusively to the PAG. We observed no projections either to rostral targets, such as the septum and the amygdala, or to caudal ones, such as the parabrachial nuclei.
In some of the aforementioned tracer studies, the PV1 nucleus although not referred to as such was labeled, sometimes preferentially. For example, Berk and Finkelstein (1982) observed terminals in the lateral and ventrolateral PAG (case M15 in their Fig. 2I ) after injection of tritiated amino acids into the distal portion of what we now recognize as the PV1 nucleus. In addition, after injection of PHA-L into the ventrolateral subarea of the lateral hypothalamus, which encompasses the PV1 nucleus, Veening et al. (1991) reported a similar distribution pattern of terminals ventrolateral to the aqueduct and to the dorsal raphe nucleus in rats (their Fig. 5B ). Using tritiated leucin as an anterograde tracer in cats, Holstege (personal communication) recognized a similar pattern of projection from the lateral hypothalamus to the PAG.
In the present study, anterograde tracing from the PV1 nucleus in both rats and mice revealed terminal fields predominantly ventrolateral to the aqueduct on the edge of the PAG (Figs. 2C, 11 ; see also Paxinos and Franklin, 2001) . In mice, the anterograde labeling Figure 11 . Three-dimensional reconstruction of the column of terminal fields (PV1-CTF). The mouse PAG is cut at six different rostrocaudal levels, revealing the approximate localization of the major terminal field (PV1-CTF) located ventrolateral to the aqueduct. The numbers indicate the different rostrocaudal levels in the atlas of Paxinos and Franklin (2001) . The column of endings consists of two portions, a rostral (red) and a caudal (orange) field, between levels 24.0 mm and 24.9 mm, separated by a short gap (arrows) around 24.5 mm. For abbreviations, see list. Drawings modified from VanderHorst and Ulfhake (2006) . Scale bar 5 0.6 mm. from the PV1 nucleus was more precise than in rats, thereby permitting the demonstration of a column of terminal fields (PV1-CTF) with a marked degree of topographical specificity in the PAG. This PV1-CTF is more medially located than the classical ventrolateral PAGcolumn reported in the literature (Bandler et al., 1991; Bandler and Shipley, 1994; Shipley et al., 1991) , is of smaller caliber, and is axially restricted to the periphery of the PAG. The rostral target of the PV1 nucleusderived PV1-CTF is localized along the lateral edge of the Su3 region (Paxinos and Franklin, 2001) in the rostral, mesencephalic part of the PAG. Spatially, the location of the PV1-CTF corresponds to that of a clearly demarcated PV-positive terminal field (Fig. 7E) , thereby indicating that the immunoreactive endings stem mainly from the PV1 nucleus. Some faintly PV-positive neurons are also recognized in this superficial Su3 region. The connections of the Su3-containing region in rats have been studied by several groups of investigators (Maciewicz et al., 1975; Leichnetz et al., 1987; Giolli et al., 1988; Van Bockstaele et al., 1989 and have been implicated in oculomotor control (Vertes and Martin, 1988) , in cortical activation, in REM sleep (Vertes, 1984) , and, on the basis of the projection to the nucleus paragigantocellularis, also in autonomic control (Van Bockstaele et al., 1989) . In cats, a high density of [ 3 H]quinuclidinyl benzilate (QNB) binding sites (pinpointing putative muscarinic receptors) has been revealed at a similar location in the PAG (Fig. 1 in Gundlach, 1991) . A projection from the Su3 region to the nucleus gigantocellulairs pontis, which is implicated in eye movements, has also been detected (Torigoe et al., 1986) .
The caudal portion of the PV1-CTF in the metencephalic part of the PAG abuts on a previously unrecognized cluster of PV-positive neurons (Figs. 8A,B , 9G-H) at rostrocaudal levels of 24.5 to 24.84 (Paxinos and Franklin, 2001 ). This area is referred to as the substantia grisea centralis, pars ventralis in the atlas of K€ onig and Klippel (1974) , and is delineated but not named in Paxinos and Franklin (2001) . In the publications that describe the parcellation of the PAG most comprehensively (Meller and Dennis, 1986; Clements et al., 1987; Ruiz-Torner et al., 2001 ), this region is not mentioned, and is only alluded to but rarely recognized in the literature as a whole. In cats, chemical stimulation of this region with D-L-homocysteic acid leads to a decrease in both blood pressure and vasoconstrictor tone of the renal vascular bed (Carrive, 1991; Harper et al., 1991) , as well as quiescence and hyporeactivity (Depaulis et al., 1994) . In the same species, lesioning of this region has been likewise shown to elicit a decrease in blood pressure as well as to prevent compensatory adjustments in arterial pressure during hemorrhaging (Ward and Darlington, 1987a,b) . In the foreseeable future, tracer experiments involving the injection of Credependent viral constructs into the distal PV1-CTF of PV-Cre mice (Hippenmeyer et al., 2005) will help to pinpoint the targets of this anonymous group of nerve cells, which we will henceforth refer to as the PV2 nucleus.
The short spatial interruption of the PV1-CTF that is revealed in rats and mice (see gap in Figs. 2C and 11) appears to be located at the level of the mesomere 2, a transverse, slender preisthmic territory interposed between the oculomotor and the trochlear nuclei (Puelles et al., 2012) . The spatially coincidental localization of this gap in rats (Fig. 2C ) and mice (Fig. 11) is striking.
The longitudinal orientation of the PV1-CTF accords with the hypothetical "functional longitudinal modules" of the PAG but corresponds to none of the other known columns. The PV1-CTF is located medial to the ventrolateral neuronal column as described by (Bandler et al,1991) and has a much smaller diameter. The PV2 nucleus occurs in its distal portion alone. Therefore the PV1-CTF, a putative, tiny "longitudinal module" is a chemoarchitectonically heterogeneous structure. This is consistent with the postulated functional heterogeneity of the rostrocaudal axis of other columns in the PAG (Bandler et al., 1991) .
One issue that could not be unambiguously clarified in the present study relates to possible differences in the projection targets of the anteriorly located small neurons and the posteriorly located large ones in the PV1 nucleus (Meszar et al., 2012) . In rats, injections of Fluoro-Gold into the dorsolateral tegmental nucleus (caudal portion of the PV1-CTF) and into the Su3 region (rostral portion of the PV1-CTF) revealed retrograde staining of both the small and the large cells in the PV1 nucleus (Fig. 4) . In mice, injections of the same tracer into either the Su3 region (rostral PV1-CTF), or the PV2 nucleus (caudal PV1-CTF) of the PAG led to retrograde filling of the small as well as the large neurons, thereby ruling out any projection specificity.
Notwithstanding the very similar PV1-projection patterns ventrolateral to the aqueduct in the PAG of rats and mice (Figs. 2C, 11 ), some differences were observed between the two species. In rats, the PV1-CTF appears to run more caudally and to extend to the zone of the laterodorsal tegmental nucleus. In mice, more rostrally located structures, such as the EdingerWestphal nucleus, received some terminals. These discrepancies could be attributable either to differences between the two species per se, or to differences in the methodological approach.
For example, species differences in traits that are influenced by the ventrolateral PAG regions close to the PV1-CTF, e.g., vocalization, may be relevant. Depending on their affective state, rats vocalize at two different ultrasonic frequencies: 20 KHz and 50 KHz. The chirps produced at 20 KHz are implicated in situations that have a negative impact on the animals (Miczek et al., 1995) , whereas the 50-KHz chirps are emitted in situations with a positive influence (Knutson et al., 1998) . Although mice can draw on a rich repertoire of ultrasonic emissions, vocalization does not appear to be related to their affective state (Portfors, 2007) .
In conclusion, the findings of the present study confirm the existence of an elongated PV1 nucleus within the lateral hypothalamus of rodents, and demonstrate that it sends out a major projection forming a column of terminal fields (PV1-CTF) located mainly ipsilateral, ventrolateral to the aqueduct on the edge of the PAG. This cylinder of terminal fields coincides with none of the classic longitudinal subdivisions of the PAG. Minor projections end in an identical location of the contralateral PAG, in the lateral habenular nucleus, the EdingerWestphal nucleus, the reticular formation, and the laterodorsal tegmental nucleus. By virtue of its projections to a topographically restricted region ventrolateral to the aqueduct, the PV1 nucleus may presumably exert discrete functions. Testable functions of the PV1 nucleus include a possible involvement in analgesic, defensive, and sexual responses as well as in the autonomic adjustments that are indispensable for their successful expression. However, other functions unrelated to those classically attributed to the PAG are not to be excluded.
